Core Viewpoint - The Hong Kong Stock Exchange (HKEX) is proposing a series of reforms to enhance its listing mechanisms and attract more companies to list in Hong Kong, including allowing all companies to submit applications confidentially, relaxing different voting rights rules, and lowering the thresholds for secondary listings [4][8]. Group 1: Relaxation of Listing Requirements - The financial thresholds for companies seeking to adopt different voting rights structures are being lowered. The market capitalization requirement will decrease from HKD 40 billion to HKD 20 billion, and the revenue threshold will drop from HKD 10 billion to HKD 600 million [6][7]. - The ratio of different voting rights will be increased from 10:1 to 20:1, allowing management shares to have up to 20 times the voting power of ordinary shares [6][7]. - The definition of "innovative industry" companies is being broadened, allowing more companies to qualify for different voting rights structures without needing to prove they are in the "innovative industry" [6][7]. Group 2: Facilitation for Overseas Issuers - The requirements for overseas companies seeking secondary listings in Hong Kong are being significantly relaxed. The market capitalization threshold for companies returning to Hong Kong will be reduced from HKD 10 billion to HKD 6 billion [8][9]. - Clearer guidelines will be provided for companies transitioning from secondary to primary listings, enhancing the process for overseas firms to list in Hong Kong [9]. Group 3: Confidential Application Submissions - The option for confidential submission of listing applications is being expanded to all applicants, allowing companies to prepare for listing without disclosing sensitive information in unfavorable market conditions [10][11]. Group 4: Market Context and Future Implications - The proposed reforms come at a time when there is a resurgence in IPO activity in Hong Kong, with over 480 companies currently in the pipeline to list [4][8]. - The reforms aim to attract high-quality companies and long-term capital, addressing the liquidity challenges and enhancing the overall quality of listed companies in Hong Kong [18].

Core Viewpoint - The Hong Kong Stock Exchange (HKEX) is proposing a series of reforms to enhance the competitiveness of its listing mechanism, aiming to attract more companies to list in Hong Kong, with over 480 companies currently in the IPO queue [2][3]. Reform Measures - The financial threshold for companies with different voting rights is proposed to be lowered from a market capitalization of HKD 400 billion or HKD 100 billion with revenue of HKD 10 billion to a new threshold of HKD 200 billion or HKD 60 billion with revenue of HKD 6 billion [3][5]. - The ratio of different voting rights is suggested to increase from 10:1 to 20:1, allowing management shares to have up to 20 times the voting power of ordinary shares [3][5]. - The definition of "innovative industry" companies is expanded, allowing more companies to qualify for different voting rights structures without needing to prove their status as "innovative" [3][5]. Second Listing and Overseas Issuers - The reforms aim to simplify the second listing process for overseas companies, reducing the market capitalization requirement from HKD 100 billion to HKD 60 billion for companies returning to Hong Kong [6][7]. - The guidelines for transitioning from a second listing to a primary listing are being revised to provide clearer instructions for compliance [6][7]. Confidential Submission - The option for confidential submission of listing applications is being expanded to all applicants, allowing companies to prepare for listing without disclosing sensitive information during unfavorable market conditions [9][10]. Transparency and Reporting - The proposal includes enhancing the transparency of the application process by publishing the identities of all professional institutions involved in preparing listing materials when applications are returned [11]. Market Context - The HKEX has seen a resurgence in IPO activity, with 119 companies listed in 2025, raising over HKD 285 billion, marking a return to the top of the global IPO rankings [12][13]. - The average first-day gain for new stocks in 2025 was 37%, with a record low of 28% for the rate of stocks falling below their IPO price [13]. - In early 2026, the IPO market continued to thrive, with fundraising exceeding HKD 892 billion in just two months [14]. Challenges and Future Outlook - Despite the positive IPO environment, liquidity issues persist, with a significant portion of trading volume concentrated in a few large companies [16]. - A substantial amount of locked shares is set to be released in 2026, which could impact market dynamics [16]. - The proposed reforms are seen as a timely response to attract high-quality companies and long-term capital to the market [16][17].

Core Viewpoint - The company, Xiehe New Energy (00182), has received a listing eligibility letter from the Singapore Exchange regarding its proposed secondary listing, which is not an indication of the value of the company or its shares [1] Group 1 - The proposed secondary listing will not involve the issuance of new shares or any fundraising activities [1] - The company's issued ordinary shares will continue to be primarily listed and traded on the Hong Kong Stock Exchange [1]

Group 1 - GBM Resources plans to pursue a secondary listing in Hong Kong to expand its investor base and enhance its international presence [1] - The company aims to leverage the strong demand for gold investments in the region and showcase its development to a broader audience [1] - GBM Resources has a total market capitalization of approximately AUD 149 million (around HKD 751 million) as of November 18 [1] Group 2 - GBM Resources has signed a Memorandum of Understanding (MOU) with its largest shareholder, Wise Walkers Limited (WWL), to facilitate the secondary listing process [2] - WWL will cover all listing-related expenses, which will be reimbursed only after the successful secondary listing of GBM Resources [2] - The MOU is valid for 18 months and can be automatically extended for an additional 6 months if the listing process is initiated [2]

Core Viewpoint - GBM Resources plans to pursue a secondary listing in Hong Kong to expand its investor base, achieve valuation premiums, and enhance its international presence [1][2] Group 1: Company Overview - GBM Resources is an Australian mining company based in Queensland, focusing on the exploration and development of gold and copper mines [1] - The company holds a high-quality project portfolio in the Drummond Basin, including flagship projects Twin Hills, Yanda, and Mt Coolon, with a total of approximately 1.84 million ounces of JORC-compliant gold resources [1] - As of November 18, GBM Resources has a total market capitalization of approximately AUD 149 million (around HKD 751 million) [1] Group 2: Listing Plans - GBM Resources has signed a Memorandum of Understanding (MOU) with its largest shareholder, Wise Walkers Limited (WWL), to facilitate the secondary listing process on the Hong Kong Stock Exchange [2] - WWL will cover all listing-related expenses, which will be reimbursed only after the successful secondary listing of GBM Resources [2] - The MOU is valid for 18 months and will automatically extend for an additional 6 months if the listing process is initiated [2] Group 3: Shareholder Relations - WWL holds a 20% stake in GBM Resources, and its chairman, Lu Hang, was appointed as a non-executive director of GBM in August [2] - WWL is a family office originating from Hong Kong and headquartered in Melbourne, with investments spanning property, agriculture, and resources [2] - Another shareholder, Hong Kong Masun International Energy Industry Group, holds a 7.26% stake in the company [2]

Core Viewpoint - The Hong Kong Stock Exchange (HKEX) is recognized as a major global financial center, known for its market-oriented, international, and flexible IPO listing system, which attracts various types of enterprises for financing [2][4]. Group 1: Participants in IPO - The IPO process at HKEX involves multiple stakeholders, including regulatory bodies, issuers, sponsors, underwriters, and intermediary institutions [2]. - Key participants include: - Regulatory bodies such as the Hong Kong Securities and Futures Commission (SFC) overseeing market fairness and intermediary behavior [2]. - Issuers, which are companies seeking to go public and must meet HKEX listing requirements [2]. - Sponsors, who are licensed brokers responsible for due diligence and compliance [2]. - Underwriters, typically major international investment banks or Chinese brokers, handling share sales and pricing [2]. Group 2: Types of Issuance Structures - HKEX supports diverse listing structures to meet different enterprise needs, including: - H-shares for domestic companies listed overseas [2]. - Red-chip companies for foreign-registered firms with primary operations in mainland China [2]. - Weighted Voting Rights (WVR) structures allowing certain shareholders enhanced voting power [2][5]. - The introduction of Chapter 18A allows unprofitable biotech companies to list under specific conditions, focusing on R&D investment and clinical trial progress [5]. Group 3: Core Process of IPO - The typical IPO process at HKEX spans 6-12 months, with key stages including: - Preliminary preparation (3-6 months) [3]. - Submission and hearing (3-4 months) [3]. - Roadshow and pricing (1-2 weeks) [3]. - Issuance and listing (within 1 week) [3]. Group 4: Post-Issuance Regulation and Lock-Up Period - Post-issuance, companies must adhere to continuous disclosure requirements and face lock-up periods for major shareholders [6]. - Lock-up periods typically last 6 months for controlling shareholders and executives, with potential extensions [6]. - Price stabilization mechanisms may be employed by underwriters within 30 days post-listing to mitigate stock price volatility [6].

本公告僅供參考，並不構成收購、購買或認購本公司任何證券的邀請或要約。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並表明概不就因本公告全部或任何部分內容而產生 或因倚賴該等內容而引致的任何損失承擔任何責任。 本公司已按保密基準向新交所遞交建議第二上市之上市申請。截至本公告日期，本公司 尚未自新交所接獲建議第二上市之上市資格函（「上市資格函」）。 於二零二五年六月二十四日，本公司接獲中國證券監督管理委員會（「中國證監會」） 就建議第二上市發出之境外發行上市備案通知書。 董事相信，完成建議第二上市後，將使本公司能夠進入新加坡證券市場。預期此舉將加 強本集團於該市場之地位，並提升本公司的全球知名度，從而助力國際業務拓展。儘管 建議第二上市不會涉及在新加坡進行任何股權籌資，惟本公司預計建議第二上市將擴闊 其股東基礎，及開闢未來額外籌資渠道。長遠而言，預期這將推廣本公司之企業形象及 提升其證券之流動性。 本公司將於必要時根據適用法律及法規就建議第二上市作出進一步公告。 建議於新加坡交易所作第二上市 China Medical System Holding ...

Core Viewpoint - EHang Intelligent, a producer of electric vertical takeoff and landing (eVTOL) aircraft, is considering a secondary listing outside of the United States [1] Group 1 - The Chief Financial Officer, Conor Yang, stated that the company is actively exploring various options for listing outside of the U.S. [1]